Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey.
Pharmacoepidemiol Drug Saf
; 28(8): 1035-1044, 2019 08.
Article
em En
| MEDLINE
| ID: mdl-31148288
ABSTRACT
PURPOSE:
This review summarises the current status of regulatory guidelines for the approval of biosimilars in Latin America and highlights the main barriers to effective pharmacovigilance in this region. We also report results from a survey of Latin American rheumatologists assessing their understanding of prescribing biosimilars and the pharmacovigilance of these drugs.METHODS:
We reviewed the current guidelines for the regulatory approval of biosimilars and barriers to effective pharmacovigilance in Latin American countries. Rheumatologists attending the II Pan-American League of Rheumatology Associations PANLAR Review Course (Biosimilars update) in Lima, Peru were asked to complete a short survey to determine their knowledge of biosimilars.RESULTS:
Many Latin American countries continue to lag behind Europe and the United States in establishing regulatory guidance and effective pharmacovigilance systems for biosimilars. Results from our survey also highlight a lack of awareness regarding the availability of biosimilars, their nomenclature, automatic substitution, and reporting adverse drug reactions because of these drugs.CONCLUSIONS:
The main barriers to effective pharmacovigilance in Latin America are the lack of consensus on the interchangeability of reference biologics and biosimilars, and the need for more suitably trained personnel to carry out effective postmarketing pharmacovigilance of biosimilars. Inconsistencies in biosimilar nomenclature make it difficult to adequately trace drugs and record adverse drug reactions associated with their use, creating a barrier to the global pharmacovigilance of biologics.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Aprovação de Drogas
/
Medicamentos Biossimilares
/
Farmacovigilância
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article